Use of natural plant exudates (Sanguis Draxonis) for sustained oral insulin delivery with dramatic reduction of glycemic effects in diabetic rats

被引:23
作者
Hou, ZQ
Zhang, ZX [1 ]
Zhang, CX
Huang, M
机构
[1] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Biomed Engn, Xian 710049, Peoples R China
[2] XinTai People Hosp, Dept Pharm, Shandong 271200, Peoples R China
[3] Fourth Mil Med Univ, Dept Electron Microscope, Xian 710033, Peoples R China
基金
中国国家自然科学基金;
关键词
Sanguis Draxonis; nanocapsules; hypoglycemic; oral; drug delivery;
D O I
10.1016/j.jconrel.2004.03.033
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Sanguis Draxonis (SD), a kind of natural plant exudates, has been prescribed for handling diabetic disorders as a Chinese traditional herb. Surprisingly, SD was found to be a good material for oral insulin delivery. The Insulin-loaded Sanguis Draxonis nanocapsules (ISDN) were prepared by deposition technique. The average size and width of distribution of ISDN were 184 +/- 24 and 110 +/- 16 nm, respectively. The insulin encapsulation efficiency of ISDN reached up to 69.6 +/- 5.6%. In vitro the release profile of insulin from ISDN can be well modeled using an exponential function [Y = 1-exp(-0.0275t)], showing that there was no initial burst release of insulin. The stability studies indicated that the majority of initial amount of insulin in ISDN was preserved not only after incubation of ISDN in three kinds of proteolytic enzyme solutions at 37degreesC for 30 min, but also after its storage at 25degreesC for 6 months. After a single oral administration of ISDN at the dose of 25, 50, and 75 IU/kg in STZ-induced diabetic rats, the blood glucose level was depressed to 60.5 +/- 2.7%, 52.6 +/- 2.3% and 47.3 +/- 3.1% of the initial value at time point 8 h, respectively, and these marked decreases lasted 2-4 days. When I-125-labeled ISDN was administered orally, the distribution sequence of isotope intensity of I-125 radioactivity in rat organs was as follows: liver, kidney, heart, spleen and lung. In addition, I-125 radioactivity disappeared progressively as a function of time, parallel to the biological effect. In conclusion, the results demonstrate that ISDN elicits a long-term hypoglycentic effect significantly after oral administration in STZ-induced diabetic rats and it can be considered as a stable and effective system for oral insulin delivery. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 25 条
[1]   TRANSMUCOSAL PASSAGE OF POLYALKYLCYANOACRYLATE NANOCAPSULES AS A NEW DRUG CARRIER IN THE SMALL-INTESTINE [J].
APRAHAMIAN, M ;
MICHEL, C ;
HUMBERT, W ;
DEVISSAGUET, JP ;
DAMGE, C .
BIOLOGY OF THE CELL, 1987, 61 (1-2) :69-76
[2]  
BAY L, 2001, Patent No. 6180140
[3]   Oral insulin delivery [J].
Carino, GP ;
Mathiowitz, E .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (2-3) :249-257
[4]   Human insulin: Basic sciences to therapeutic uses [J].
Chien, YW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (08) :753-789
[5]   Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin [J].
Damge, C ;
Vranckx, H ;
Balschmidt, P ;
Couvreur, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) :1403-1409
[6]   NEW APPROACH FOR ORAL-ADMINISTRATION OF INSULIN WITH POLYALKYLCYANOACRYLATE NANOCAPSULES AS DRUG CARRIER [J].
DAMGE, C ;
MICHEL, C ;
APRAHAMIAN, M ;
COUVREUR, P .
DIABETES, 1988, 37 (02) :246-251
[7]   Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers [J].
Dorkoosh, FA ;
Verhoef, JC ;
Borchard, G ;
Rafiee-Tehrani, M ;
Verheijden, JHM ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 247 (1-2) :47-55
[8]  
ERMAK TH, 1995, CELL TISSUE RES, V279, P433, DOI 10.1007/BF00318501
[9]  
FENG P, 1999, ION EXCH ADSORPT, V15, P64
[10]  
GERARDO P, 2000, J CONTROL RELEASE, V65, P261